Hims & Hers Health shares gain more than 5% after price action confirms trend alignment above key moving averages

Traders Union
All News
Financial News
Hims & hers health surges 5.09% today

Highlights

Hims & Hers Health exhibits sustained bullish momentum, trading above key moving averages across all timeframes.
Technical signals are predominantly positive, with buying pressure dominant and volatility elevated, though some oscillators show mixed or neutral momentum.
Expected five-session price range is $34.71–$38.49, with an over 80% probability of an upward move while $36.96 remains the major resistance.

Anton Kharitonov, expert at Traders Union, notes that Hims & Hers Health’s upside is driven almost exclusively by technical factors without fresh news or evident fundamental catalysts. He emphasizes that reliance on momentum signals and moving averages can create vulnerability if the broader market shifts out of risk-on mode. Some indicators suggest overbought risk and neutral momentum, and supportive price action has not yet breached major resistance at $36.96. Kharitonov cautions that volatile sessions could trigger a quick reversal if buyers lose control. "I remain skeptical of sustainability here, as lacking news or institutional buying increases drawdown risk despite the current technical uptrend."

Viktoras Karapetjanc, expert at Traders Union, views the technical rally in Hims & Hers Health as a confirmation of strong investor confidence and continued demand. He sees the alignment above all key moving averages as reinforcing a bullish market structure. With volatility high and buyers dominating, Karapetjanc expects further growth if resistance at $36.96 is cleared. He maintains that the absence of news has not dampened appetite for risk. "I see strong setup potential — the bullish structure remains intact and further upside is likely if momentum persists above $34.71."

Parshwa Turakhiya, analyst, recognizes that short-term sentiment has fueled aggressive buying in Hims & Hers Health. He observes that intraday volatility creates tactical trading opportunities around the $34.71 to $38.49 range. Technical readings suggest momentum bias, but warns of overbought risks if the rally extends too quickly. Turakhiya advises closely tracking price action near support and resistance levels for swift trade adjustments. "I recommend traders watch for momentum shifts and be ready to capitalize on any breakout or reversal setups this week."

Bullish momentum holds as price action nears resistance

Hims & Hers Health is trading above its 20-day, 50-day, and 200-day moving averages ($34.36, $29.39, and $32), which reinforces a positive trend in the short, medium, and long term. The price action is supported by the Ichimoku Kijun at $32.24. Nearest resistance is visible at $36.96, with support at $36.4. Momentum signals are broadly bullish: MACD and ADX are in 'buy' mode, RSI is rising but remains below overbought, and Stochastic RSI readings show an oversold signal. CCI and Awesome Oscillator suggest neutral momentum, while intraday action is dominated by buyers as indicated by a Bull/Bear Power reading of 0.6, though overbought risk persists. The stock displays strong session highs and active volatility at 3.62%.

Earlier, analysts noted that persistent bullish momentum and strong technical alignment were driving Hims & Hers Health higher. The latest surge reinforces this outlook, with the critical focus now shifting to whether the stock can decisively break above the $36.96 resistance, which could act as a catalyst for further upside movement.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.